Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Accurate assessment of treatment response and residual disease is indispensable for the evaluation of cancer treatment efficacy. However, performing tissue biopsies for longitudinal follow-up poses a major challenge in the management of solid tumours like neuroblastoma. In the present study, we eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Goethem, Alan, Deleu, Jill, Yigit, Nurten, Everaert, Celine, Moreno-Smith, Myrthala, Vasudevan, Sanjeev A, Zeka, Fjoralba, Demuynck, Fleur, Barbieri, Eveline, Speleman, Frank, Mestdagh, Pieter, Shohet, Jason, Vandesompele, Jo, Van Maerken, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cancer-specific RNAs and RNA Processing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846426/
https://www.ncbi.nlm.nih.gov/pubmed/36683916
http://dx.doi.org/10.1093/narcan/zcad002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846426/
https://www.ncbi.nlm.nih.gov/pubmed/36683916
http://dx.doi.org/10.1093/narcan/zcad002

Ejemplares similares